Ranbaxy Report

Only available on StudyMode
  • Topic: Ranbaxy Laboratories, Skill, Donald Kirkpatrick
  • Pages : 15 (4244 words )
  • Download(s) : 597
  • Published : December 14, 2010
Open Document
Text Preview
Metrics Used to Measure Training
Impact At Ranbaxy

L.N.D. Report

Compiled By:
Group 5
Aditi
Chahana
Nayan
Prasun
Priyam

Under the Guidance of
Prof. A. U. Bhaskar

Acknowledgement

All of us together have put in constant efforts in the making of this report. However, it would not have been successful without the kind support, help and guidance of all our mentors. We would like to extend our sincere thanks to all of them without which this would not have been possible.

We are highly obliged to Mr. A. U. Bhaskar for his guidance and constant support, as well as for providing necessary information regarding the project.

We would like to express our sincere gratitude towards Ms. Ruchira Gupta, General Manager-HR, Ranbaxy. She very kindly consented to spare some time for us to and gave us a very insightful view of Ranbaxy’s Recruitment Process. Her valuable insights about the organization helped us in the making of this project and also gave us a holistic view on the subject. We would also like to express our special gratitude and thanks to other staff and Ranbaxy employees for providing with such attention and time.

Our thanks and appreciations also go to our group members in accomplishing the project.

Index

i. Ranbaxy.….……………………………………..…………………………..5 ii. Training At Ranbaxy….…………………………………………..……….5 iii. Kirkpatrick Model……..……………………………………………...…...8 iv. Level 1………...…….……………………………………………...……...11 v. Feedback Form…………………………………………………...………12 vi. Level 2……………………………………………………………………..14 vii. Level 3…………………………..………………………………………...17 viii. Level 4………………………………………………………………...….19 ix. References……………………………………………………………….22

Executive Summary

Ranbaxy is one of India's largest pharmaceutical companies. Japanese company Daiichi Sankyo gained majority control in 2008.Ranbaxy is an Rs.4000crore company with a profit of s.571.98crore in 2010. Ranbaxy does not have a separate facility for conducting its training programs, but it has a separate department to deal with its training requirements – Global Organization and Training Department. The Kirkpatrick Model is one the most well-known and used model for measuring the effectiveness of training programs. This model analyses the impact of a training program on four progressive levels. We have analyzed the metrics used by Ranbaxy to measure the impact of training on these four levels. Eg.: Level 1 we have used a feedback form that Ranbaxy uses to check the immediate response of the trainee after training. At level 2 Ranbaxy uses extended training sessions like calling the trainer for help with real time problems after the training is over. At level 3 the behavioral evaluation is tough to be talked about in numbers and hence at Ranbaxy for level 3 evaluation generally the trainees’ behavior is monitored for any changes. At level 4, come the actual results, Ranbaxy uses various ratios like yield ratios for negotiations and sales, also uses timelines for HR department, sales, SLAs of shared services department.

Ranbaxy Laboratories Limited:

Ranbaxy is one of India's largest pharmaceutical companies. Incorporated in 1961, Ranbaxy exports its products to 125 countries with ground operations in 46 and manufacturing facilities in seven countries. The company went public in 1973, and Japanese company Daiichi Sankyo gained majority control in 2008. Ranbaxy is an Rs.4000crore company with a profit of Rs.571.98crore in 2010. This was after a loss of Rs.1044.88crore last year. According to the financial report, the company is growing at a healthy 13% as compared to last year. For the year 2009, the Company recorded Global Sales of US $ 1519 Mn. The Company has a balanced mix of revenues from emerging and developed markets that contribute 54% and 39% respectively. In 2009, North America, the Company's largest market contributed sales of US $ 397 Mn, followed by Europe garnering US $ 269 Mn and Asia clocking sales of around US $ 441 Mn....
tracking img